ArticleExpert opinion on orphan drugs2022

Drugs and biologics receiving FDA orphan drug designation: an analysis of the most frequently designated products and their repositioning strategies.

Kathleen L Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.